Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.

Patwardhan, V R; Sengupta, N; Bonder, A; Lau, D; Afdhal, N H

Patwardhan, V R; Sengupta, N; Bonder, A; Lau, D; Afdhal, N H.

Affiliation

Patwardhan VR; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Aliment Pharmacol Ther ; 40(7): 804-10, 2014 Oct.

Article in En | MEDLINE | ID: mdl-25109610

Subject(s)

Antiviral Agents/therapeutic use; Hepatitis B, Chronic/drug therapy; Nucleosides/therapeutic use; Nucleotides/therapeutic use; Adenine/analogs & derivatives; Adenine/therapeutic use; Adult; Female; Guanine/analogs & derivatives; Guanine/therapeutic use; Hepatitis B e Antigens; Humans; Lamivudine/therapeutic use; Male; Middle Aged; Organophosphonates/therapeutic use; Recurrence; Tenofovir; Withholding Treatment; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B, Chronic / Nucleosides / Nucleotides Type of study: Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google